Breure, A.M.

Casellas, M.

Craft, J.

Dagot, C.

Frew, R.G.

Helwig, K.P.M.

Hunter, C.

Klepiszewski, K.

Lachassagne, D.

Levi, Y.

Lyko, S.

MacLachlan, J.

McNaughtan, M.L.

Nafo, I.

Pahl, O.

Perrodin, Y.

Ploy, M.C.

Roberts, J.B.

Shu, X.

Stalder, T.

Wiest, C.

English

NARCIS 

Pharmaceuticals in sewage systems and surface waters – status quo

Radboud Repository

This Chapter summarises new findings and insights relating to the occurrence of pharmaceuticals in the environment. With the introduction of the ‘Watch List’, which now features several pharmaceuticals (Table 3.1), a quantitative understanding of sources, available dilution and resulting concentrations of pharmaceuticals occurring in the aquatic environment remains important. Surface water measurement campaigns in the partner countries provide a useful ‘snapshot’ of levels of pharmaceuticals found in environmental waters, whereas waste water treatment plant (WWTP) influent and effluent concentrations, especially in combination with flow data, offer insights into the load discharged into the environment and dilution required to keep environmental concentrations below target levels, should these be set in the future. Sewage sludge is in some countries spread on agricultural land in the interest of nutrient cycling. Effects of pharmaceuticals on grazing animals have been established by Bellingham et al. (2012). Section 3.2 reports on concentrations and loads encounteredin the course of our sampling campaigns in WWTP, rivers and sludges, including on the effect of stabilisation treatments on concentrations and partitioning of pharmaceuticals in sludge

McNaughtan, M.

ResearchOnline@GCU

Pharmaceuticals in sewage systems and surface waters:status quo

Pharmaceuticals in sewage systems and surface waters – status quo

Abstract

Similar works

Full text

Available Versions

NARCIS

Radboud Repository

ResearchOnline@GCU